Weizmann Institute of Science, Rehovot
Vascular parameters on MRI separate benign and malignant breast lesions
Published in Lab Business Week, October 9th, 2005
According to recent research from Israel, "tumor perfusion through the microvascular network can be imaged noninvasively by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). The objective of the current study was to quantity the microvascular perfusion parameters in various human breast lesions and to determine whether they varied between benign lesions and malignancy and whether they were altered with increased invasiveness."
"Perfusion parameters in 22 benign fibrocystic changes, 15 ductal carcinomas in situ (DCIS), 30 infiltrating ductal carcinomas (IDC), and 22...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-10-09)
More Articles from Lab Business Week
- Access Pharmaceuticals
Targeted drug delivery company reports status of convertible notes - Alexion Pharmaceuticals, Inc.
Vikas Sinha named senior VP and CFO for cardiovascular drug maker - Algeta ASA
Cancer drug developer raises EUR 23 million in series A round - Amicus Therapeutics
Pharmacological chaperone developer raises $55M in financing - Anadys Pharmaceuticals
Pharmaceutical company names member to board of directors - Ascentia Biomedical Corp.
Cancer drug developer receives $1M funding commitment - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
